Raul  Parra, Jr. net worth and biography

Raul Parra, Jr. Biography and Net Worth

Raul Parra, CPA, has been Merit’s Chief Financial Officer since July 2018 and served as Interim Chief Financial Officer from May 31, 2018, to July 2018. He has also served as Merit’s Vice President of Accounting since February 2016 and was Merit’s Corporate Controller from July 2012 to January 2015.

Parra served in other accounting-related capacities with Merit, including Director of Financial Reporting from December 2009 to July 2012. Prior to joining Merit, Parra was employed as an auditor by Deloitte & Touche LLP from 2003 to 2009.

He holds a Bachelor of Science degree in Business Administration, with an emphasis in accounting, from Sonoma State University. He is a certified public accountant.

How do I contact Raul Parra, Jr.?

The corporate mailing address for Mr. Parra, Jr. and other Merit Medical Systems executives is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. Merit Medical Systems can also be reached via phone at (801) 253-1600 and via email at [email protected]. Learn More on Raul Parra, Jr.'s contact information.

Has Raul Parra, Jr. been buying or selling shares of Merit Medical Systems?

Raul Parra, Jr. has not been actively trading shares of Merit Medical Systems in the last ninety days. Learn More on Raul Parra, Jr.'s trading history.

Who are Merit Medical Systems' active insiders?

Merit Medical Systems' insider roster includes A. Anderson (Director), Jill Anderson (Director), David Floyd (Director), Ronald Frost (COO), Thomas Gunderson (Director), Fred Lampropoulos (Founder, Chairman and CEO), Brian Lloyd (Insider), F. Millner (Director), Raul Parra, Jr. (CFO), Neil Peterson (COO), Michel Voigt (Insider), Lynne Ward (Director), and Joseph Wright (Insider). Learn More on Merit Medical Systems' active insiders.

Are insiders buying or selling shares of Merit Medical Systems?

In the last twelve months, insiders at the medical instruments supplier sold shares 8 times. They sold a total of 131,783 shares worth more than $11,203,323.63. The most recent insider tranaction occured on November, 15th when Director F. Ann Millner sold 12,500 shares worth more than $1,269,375.00. Insiders at Merit Medical Systems own 3.7% of the company. Learn More about insider trades at Merit Medical Systems.

Information on this page was last updated on 11/15/2024.

Raul Parra, Jr. Insider Trading History at Merit Medical Systems

See Full Table

Raul Parra, Jr. Buying and Selling Activity at Merit Medical Systems

This chart shows Raul Jr. Parra's buying and selling at Merit Medical Systems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Merit Medical Systems Company Overview

Merit Medical Systems logo
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Read More

Today's Range

Now: $98.22
Low: $95.51
High: $99.04

50 Day Range

MA: $100.75
Low: $94.90
High: $105.52

2 Week Range

Now: $98.22
Low: $70.70
High: $108.07

Volume

1,433,879 shs

Average Volume

346,824 shs

Market Capitalization

$5.72 billion

P/E Ratio

48.15

Dividend Yield

N/A

Beta

0.84